Clinical Trial Update: Comparative Evaluation of Results of Allogeneic Hematopoietic Stem Cells Versus Ponatinib in CML Patients Carrying a Mutation T315I

View source ↗

Summary

This trial compares the outcomes of allogeneic hematopoietic stem cell transplantation versus ponatinib in chronic myeloid leukemia patients with the T315I muta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Allogeneic hematopoietic stem cell transplantation
• Ponatinib (ponatinib)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Leukemia | Status: COMPLETED